SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-128633
Filing Date
2021-10-21
Accepted
2021-10-21 20:46:33
Documents
2
Period of Report
2021-10-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2130646-9_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2130646-9_3seq1.xml 3 1608
2 EXHIBIT 99.1 tm2130646d9_ex99-1.htm EX-99.1 8078
  Complete submission text file 0001104659-21-128633.txt   11017
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 828 WINTER STREET SUITE 300 WALTHAM MA 02451
Business Address
Curran Daniel J. (Reporting) CIK: 0001887599 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40925 | Film No.: 211338440